Endpoints News senior editor Amber Tong is leaving the biopharma news site for a new opportunity.
In addition to writing on the biggest scientific and business updates of the day, she steers coverage decisions for the newsroom and sets the agenda before the U.S. and Europe are awake. She has a particular focus on oncology, and how technologies developed for cancer are being used in other diseases.
Working out of Hong Kong, she has also helped bring attention to the growing role Asia plays on the global biopharma stage.
Tong is a graduate of Rice University, with a degree in anthropology.
Bloomberg Industry Group is looking for a reporter with a proven track record of breaking…
Molly Callaghan has been hired to cover the New Mexico Inno, technology and energy beats…
Albuquerque Business First has hired Cooper Metts to cover commercial and residential real estate. He earned bachelor’s…
Forbes is starting a science and technology newsletter written by senior editor Alex Knapp. Knapp writes,…
The Houston Landing has hired former Wall Street Journal staffer Dion Nissenbaum as a reporter. He…
Katie Davies has been hired as U.S. editor-in-chief of DailyMail.com in New York. Davies will…